Literature DB >> 17590695

Vitiligo: Epidemiology and clinical pattern at King Khalid University Hospital.

J S Jarallah1, O A Al-Sheikh, M El-Shabrawy, M A Al-Wakeel.   

Abstract

The incidence of vitiligo at King Khalid University Hospital (KKUH), Riyadh, Saudi Arabia was 2.5% for the period from 1985-1990. The majority (96.1%) were Saudis. Approximately 64% were below the age of 30 years and the average was 25.6+/- SD 13.7 years. Fifty-six percent of the patients were males and 43% were females. More than half of the patients had the lesions for a period between one and nine years and 17.17% had them for more than 15 years. Only 12% had a positive family history of vitiligo. The majority (54%) of the lesions were in exposed areas. The associated diseases with vitiligo are also reported. It appears that the clinical pattern of vitiligo is not different from what is reported in other studies.

Entities:  

Year:  1993        PMID: 17590695     DOI: 10.5144/0256-4947.1993.332

Source DB:  PubMed          Journal:  Ann Saudi Med        ISSN: 0256-4947            Impact factor:   1.526


  4 in total

1.  Prevailing Misconceptions of Vitiligo among Saudi School Children.

Authors:  Fawzy Khalil Sharaf
Journal:  Int J Health Sci (Qassim)       Date:  2014-01

2.  Identifying Patients at Higher Risk of Depression Among Patients with Vitiligo at Outpatient Setting.

Authors:  Mana Abdullah Alharbi
Journal:  Mater Sociomed       Date:  2020-06

3.  Chronic diseases among vitiligo patients. A case control study.

Authors:  Abdullah O Al Houssien; Rana O Al Houssien; Waleed Al Ajroush; Hassan S Al Kahtani
Journal:  Saudi Med J       Date:  2017-04       Impact factor: 1.484

4.  Variations in TAP1 and PSMB9 Genes Involved in Antigen Processing and Presentation Increase the Risk of Vitiligo in the Saudi Community.

Authors:  Ahmad H Mufti; Imad A AlJahdali; Nasser A Elhawary; Samar N Ekram; Iman Abumansour; Ikhlas A Sindi; Hind Naffadi; Ezzeldin N Elhawary; Najiah M Alyamani; Ghydda Alghamdi; Wafaa Alosaimi; Ghufran Rawas; Amaal Alharbi; Mohammed T Tayeb
Journal:  Int J Gen Med       Date:  2021-12-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.